title: Salvage therapy with azacitidine increases regulatory T cells in peripheral blood of patients with AML or MDS and early relapse after allogeneic blood stem cell transplantation.
authors.forename: T
authors.initials: T
authors.lastname: Schroeder
authors.forename: J
authors.initials: J
authors.lastname: Fröbel
authors.forename: R-P
authors.initials: RP
authors.lastname: Cadeddu
authors.forename: A
authors.initials: A
authors.lastname: Czibere
authors.forename: A
authors.initials: A
authors.lastname: Dienst
authors.forename: U
authors.initials: U
authors.lastname: Platzbecker
authors.forename: G
authors.initials: G
authors.lastname: Bug
authors.forename: L
authors.initials: L
authors.lastname: Uharek
authors.forename: R
authors.initials: R
authors.lastname: Fenk
authors.forename: U
authors.initials: U
authors.lastname: Germing
authors.forename: N
authors.initials: N
authors.lastname: Kröger
authors.forename: R
authors.initials: R
authors.lastname: Haas
authors.forename: G
authors.initials: G
authors.lastname: Kobbe
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D001374:Azacitidine / Q000627:therapeutic use*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000097:blood* / Q000188:drug therapy*; D018655:Lymphocyte Count; D009190:Myelodysplastic Syndromes / Q000097:blood* / Q000188:drug therapy*; D012008:Recurrence; D016879:Salvage Therapy; D050378:T-Lymphocytes, Regulatory; D014184:Transplantation, Homologous
chemical_list: D000964:Antimetabolites, Antineoplastic; D001374:Azacitidine